Vol. 19 No. 2 (2015)
CARDIOLOGY

Preventive pulmonary vein isolation in patients with cavotricuspid isthmus ablation: PREVENT-AF Study I

PDF (Русский)
  • S. Bairamova,
  • A. Romanov,
  • S. Artemenko,
  • V. Shabanov,
  • D. Losik,
  • A. Karaskov,
  • Ye. Pokushalov
S. Bairamova
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
A. Romanov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
S. Artemenko
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
V. Shabanov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
D. Losik
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
A. Karaskov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
Ye. Pokushalov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, 15 Rechkunovskaya Str., 630055, Novosibirsk, Russian Federation
Bio
DOI: https://doi.org/10.21688/1681-3472-2015-2-93-101

Published 2015-10-12

Keywords

  • atrial flutter,
  • atrial fibrillation,
  • catheter ablation,
  • cavotricuspid isthmus,
  • pulmonary vein isolation,
  • prevention
    • ...More
    Less

How to Cite

Bairamova, S., Romanov, A., Artemenko, S., Shabanov, V., Losik, D., Karaskov, A., & Pokushalov, Y. (2015). Preventive pulmonary vein isolation in patients with cavotricuspid isthmus ablation: PREVENT-AF Study I. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(2), 93–101. https://doi.org/10.21688/1681-3472-2015-2-93-101

Copyright (c) 2015 Bairamova S.A., Romanov A.B., Artemenko S.N., Shabanov V.V., Losik D.V., Karaskov A.M., Pokushalov Ye.A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Background. Although catheter ablation of isthmus-dependent atrial flutter (AFL) is extremely successful at eliminating the target arrhythmia, many patients subsequently experience a new onset of atrial fibrillation (AF) due to shared mechanisms. The development of AF may necessitate additional interventions and expose patients to long-term risks.
Objective. The study was designed to test a hypothesis whether it is possible to keep AF down during cavotricuspid isthmus (CTI) ablation.
Methods. This prospective blind randomized study included 50 patients with detected AFL, without AF in the medical history. The patients were randomized to undergo either CTI ablation alone or CTI with concomitant pulmonary vein isolation (PVI). All patients received an implantable loop recorder (ILR) during the ablation procedure.
Results. CTI ablation was successful in all 50 patients. PVI was effective in all 25 patients randomized to CTI+PVI group, with no complications recorded in both groups. The procedure (p<0.0001) and fluoroscopy (p<0.0001) times were longer in the CTI+PVI group. More patients in the CTI alone group experienced a new onset of AF, 52% vs 12%, during follow-up for minimum of one year (p=0.005). No patient experienced recurrent AFL. The one-year AF burden on ILR also favored the CTI+PVI group compared to the CTI alone group: 8.3% vs 4.0% (p=0.034). In the CTI alone group, 32% patients subsequently required another ablation for AF. PVI and female gender proved to be independent predictors of freedom from AF.
Conclusions. The PREVENT-AF Study I trial results show that the addition of PVI to CTI ablation for patients with typical AFL only leads to a marked reduction of a new onset of AF during clinical follow-up as assessed by implantable ILR.

PDF (Русский)

References

  1. Babaev A., Suma V., Tita C., Steinberg J.S. Recurrence rate of atrial flutter after initial presentation in patients on drug treatment // Am. J. Cardiol. 2003. Vol. 92. P. 1122–1124.
  2. Natale A., Newby K.H., Pisano E., et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter // J. Am. Coll. Cardiol. 2000. Vol. 35. P. 1898–1904.
  3. Ellis K., Wazni O., Marrouche N., Martin D., Gillinov M., McCarthy P., Saad E.B., Bhargava M., Schweikert R., Saliba W., Bash D., Rossillo A., Erciyes D., Tchou, P., 4. Natale A. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter: Leftatrial size as an independent predictor of atrial fibrillation recurrence // J. Cardiovasc. Electrophysiol. 2007. Vol. 18. P. 799–802.
  4. Luria D.M., Hodge D.O., Monahan K.H., Haroldson J.M., Shen W.K., Asirvatham S.J., Hammill S.C., Munger T.M., Glikson M., Gersh B.J., Paker D.L., Friedman P.A. Effect of radiofrequency ablation of atrial flutter on the natural history of subsequent atrial arrhythmias // J. Cardiovasc. Electrophysiol. 2008. Vol. 19. P. 1145–1150.
  5. Perez FJ, Schubert CM, Parvez B, Pathak V, Ellenbogen KA, Wood MA. Long-term outcomes after catheter ablation of cavotricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol 2009; 2: 393–401.
  6. Waldo A.L., Feld G.K. Inter-relationships of atrial fibrillation and atrial flutter. Mechanisms and clinical implications // J. Am. Coll. Cardiol. 2008. Vol. 51. P. 779–786.
  7. Wazni O., Marrouche N.F., Martin D.O., et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein -left atrial disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation // Circulation. 2003. Vol. 108. P. 2479–2483.
  8. Mittal S., Pokushalov E., Romanov A., Ferrara M., Arshad A., Musat D., Preminger M., Sichrovsky T., Steinberg J.S. // Heart Rhythm 2013. Vol. 10. P. 1598–1604.
  9. Gilligan D.M., Zakaib J.S., Fuller I., Shepard R.K., Dan D., Wood M.A., Clemo H.F., Stambler B.S., Ellenbogen K.A. Long-term outcome of patients after successful radiofrequency ablation for typical atrial flutter // PACE. 2003. Vol. 26. P. 53–58.
  10. Da Costa A., Romeyer-Bouchard C., Zarquane-Sliman N., Messier M., Samuel B., Kihel A., Faure E., Isaaz K. Impact of first line radiofrequency ablation in patients with lone atrial flutter on the long term risk of subsequent atrial fibrillation // Heart. 2005. Vol. 91. P. 97–98.
  11. Da Costa A., Romeyer C., Mourot M., Messier A., Cerisier A., Faure E., Isaaz K. Factors associated with early atrial fibrillation after ablation of common atrial flutter // Eur. Heart J. 2002. Vol. 23. P. 498–506.
  12. Ellis K., Wazni O., Marrouche N., et al. Incidence of atrial fibrillation post-cavotricuspid isthmus ablation in patients with typical atrial flutter // J. Cardiovasc. Electrophysiol. 2007. Vol. 18. P. 799–802.
  13. Pokushalov E., Romanov A., Corbucci G., Artyomenko S., Turov A., Shirokova N., Karaskov A. Ablation of paroxysmal and persistent atrial fibrillation: 1-year follow-up through continuous subcutaneous monitoring // J. Cardiovasc. Electrophysiol. 2011. Vol. 22. P. 369–375.
  14. Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS / EHRA / ECAS Expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management // Europace. 2012. Vol. 14. P. 528–606.
  15. Navarrete A., Conte F., Moran M., Ali I., Milikan N. Ablation of atrial fibrillation at the time of cavotricuspid isthmus ablation in patients with atrial flutter without documented atrial fibrillation derives a better long-term benefit // J. Cardiovasc. Electrophysiol. 2011. Vol. 22. P. 34–38.